Planet 13 Holdings (PLNH) Liabilities and Shareholders Equity (2021 - 2026)

Planet 13 Holdings (PLNH) reported Liabilities and Shareholders Equity of $146.9 million for Q1 2026, down 27.91% year-over-year from $203.8 million in Q1 2025, and down 3.52% quarter-over-quarter from $152.3 million in Q4 2025.

Planet 13 Holdings (PLNH) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $146.9 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $146.9 million, down 27.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $658.7 million (down 26.48% YoY), and the FY2025 annual result was $152.3 million, down 26.34% from the prior year.
  • Liabilities and Shareholders Equity declined to $146.9 million in Q1 2026 per PLNH's latest filing, from $152.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $274.0 million in Q1 2022 and troughed at $146.9 million in Q1 2026.
  • A 5-year average of $204.1 million and a median of $206.7 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity plunged 38.46% in 2023, then soared 49.89% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $220.1 million in 2022, then slumped by 31.04% to $151.7 million in 2023, then soared by 36.24% to $206.7 million in 2024, then retreated by 26.34% to $152.3 million in 2025, then decreased by 3.52% to $146.9 million in 2026.
  • Business Quant data shows PLNH's Liabilities and Shareholders Equity at $146.9 million in Q1 2026, $152.3 million in Q4 2025, and $158.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Planet 13 Holdings - - 9.41 Mn 146.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 146.91 Mn
Dec 31, 2025 152.28 Mn
Sep 30, 2025 158.50 Mn
Jun 30, 2025 200.98 Mn
Mar 31, 2025 203.79 Mn
Dec 31, 2024 206.73 Mn
Sep 30, 2024 242.96 Mn
Jun 30, 2024 242.43 Mn
Mar 31, 2024 157.39 Mn
Dec 31, 2023 151.75 Mn
Sep 30, 2023 162.10 Mn
Jun 30, 2023 206.70 Mn
Mar 31, 2023 211.48 Mn
Dec 31, 2022 220.06 Mn
Sep 30, 2022 263.41 Mn
Jun 30, 2022 268.44 Mn
Mar 31, 2022 274.00 Mn
Dec 31, 2021 213.81 Mn